Details of the Drug Formulaction

General Information of Drug Formulation (ID: F01618)

• Formulation Name: Aspirin 325 mg tablet
• Company: Achlis Laboratories

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Aspirin	(DM672AH)	Acute coronary syndrome	BA41	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
FD&C blue no. 2	(E00446)	2723854	Colorant
Glyceryl monostearate	(E00310)	24699	Emollient; Emulsifying agent; Emulsion stabilizing agent; Solubilizing agent; Surfactant; Viscosity-controlling agent
Hydrazine yellow	(E00409)	164825	Colorant
Polyethylene glycol 6000	(E00655)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Quinoline yellow WS	(E00309)	24671	Colorant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium bicarbonate	(E00424)	516892	Alkalizing agent; Diluent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triethyl citrate	(E00128)	6506	Plasticizing agent; Solvent
Vinylpyrrolidone	(E00668)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent